Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19
Andrea B. Troxel, Eva Petkova, Keith Goldfeld, et al.
JAMA Network Open (2022) Vol. 5, Iss. 1, pp. e2147331-e2147331
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 375
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
An overview on the treatments and prevention against COVID-19
Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 48
Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma
Hyung Park, Thaddeus Tarpey, Mengling Liu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 1, pp. e2147375-e2147375
Open Access | Times Cited: 35
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 22
High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020
Shuting Zhang, Peijun Ma, Marek Orzechowski, et al.
mBio (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 10
Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation
Hyung Park, Chang Yu, Liise‐anne Pirofski, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Generating the Evidence Base for Convalescent Plasma Use for a New Infectious Disease
Hyunah Yoon, Liise‐anne Pirofski
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Lack of efficacy of convalescent plasma in COVID‐19 patients with concomitant hematological malignancies: An Italian retrospective study
Francesco Lanza, Federica Monaco, Fabio Ciceri, et al.
Hematological Oncology (2022) Vol. 40, Iss. 5, pp. 857-863
Open Access | Times Cited: 13
Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Convalescent Plasma Therapy, Therapeutic Formulations of Repurposed Drugs in 20th Century Epidemics against COVID-19: A Systematic Review
Diego Fernández-Lázaro, Carlos Domínguez Ortega, Nerea Sánchez-Serrano, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1020-1020
Open Access | Times Cited: 10
Effect of SARS-CoV-2 IgG Seroconversion After Convalescent Plasma Transfusion on Hospital Outcomes in COVID-19
Sonal Pannu, Michael H. Cardone, Mohankumar Doraiswamy, et al.
CHEST Critical Care (2024) Vol. 2, Iss. 2, pp. 100048-100048
Open Access | Times Cited: 1
Impact of the PATH Statement on Analysis and Reporting of Heterogeneity of Treatment Effect in Clinical Trials: A Scoping Review
Joe V. Selby, Carolien C. H. M. Maas, Bruce Fireman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A Bayesian multivariate hierarchical model for developing a treatment benefit index using mixed types of outcomes
Danni Wu, Keith Goldfeld, Eva Petkova, et al.
BMC Medical Research Methodology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The State-of-the-Art of Gene Editing and its Application to Viral Infections and Diseases Including COVID-19
Yousef M. Hawsawi, Anwar Shams, Abdulrahman Theyab, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 8
The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials
Zhenbei Qian, Zhijin Zhang, Haomiao Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Developing a Bayesian hierarchical model for a prospective individual patient data meta-analysis with continuous monitoring
Danni Wu, Keith Goldfeld, Eva Petkova
BMC Medical Research Methodology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism
Pei Ye Li, Philip S. Yu, Allen Li, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 2, pp. 100068-100068
Open Access | Times Cited: 4
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
Katerina Jazbec, Mojca Jež, Klemen Žiberna, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19
Cindy Ke Zhou, Monica Bennett, Carlos H. Villa, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273223-e0273223
Open Access | Times Cited: 5
Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise
Edward N. Janoff, Sheldon T. Brown, Ilana Belitskaya‐Lévy, et al.
Contemporary Clinical Trials Communications (2023) Vol. 35, pp. 101190-101190
Open Access | Times Cited: 2
Use of convalescent plasma to treat COVID-19: case studies
Stéphani Caroline Beneti, Leila Larisa Medeiros Marques, Gisely de Mattos, et al.
Brazilian Journal of Biology (2023) Vol. 83
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top